Current Affairs - Sports Current Affairs
Which gene-editing technology received global approval in 2023 for treating sickle cell disease?
Which gene-editing technology received global approval in 2023 for treating sickle cell disease?
medium Q14 of 15
Step-by-Step Solution
Step 1: Recall major biotech milestone
In 2023, the UK and USA approved the first CRISPR-based gene therapy for sickle cell disease.Step 2: Identify technology
The therapy was based on CRISPR-Cas9 gene-editing technology.Final Answer:
CRISPR-Cas9 → Option CQuick Check:
First CRISPR therapy approval = 2023 ✅
Quick Trick: CRISPR = First approved gene-editing therapy (2023).
Common Mistakes:
- Confusing CRISPR with older gene-editing tools.
Master "Sports Current Affairs" in Current Affairs
Start learning the concept with an interactive lesson.
Want More Practice?
15+ quiz questions · All difficulty levels · Free
Free Signup - Practice All QuestionsMore Current Affairs Quizzes